Brett K Haumann Theravance Biopharma, Inc. (TBPH) insider trading activity

TBPH Quotes by TradingView

Brett K Haumann is Chief Medical Officer of Theravance Biopharma, Inc.. Currently has a direct ownership of 242,499 shares of TBPH, which is worth approximately $2.33 Million. The most recent transaction as insider was on Feb 20, 2021, when has been sold 35,672 shares (Ordinary Shares) at a price of $18.79 per share, resulting in proceeds of $670,277. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 242K
0% 3M change
0% 12M change
Total Value Held $2.33 Million

BRETT K HAUMANN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2021
SELL
Payment of exercise price or tax liability
$670,277 $18.79 p/Share
35,672 Reduced 12.82%
242,499 Ordinary Shares
Nov 20 2020
SELL
Payment of exercise price or tax liability
$79,837 $17.21 p/Share
4,639 Reduced 1.64%
278,171 Ordinary Shares
BKH

Brett K Haumann

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TBPH